| Thromboembolism |
1 |
1 |
| Atrial Fibrillation |
0 |
0.97 |
| Meta-Analysis |
0 |
0.68 |
| Hemorrhage |
0 |
0.8 |
| Anticoagulation Therapy |
0 |
0.5 |
| Traumatic Brain Injury |
0 |
0.2 |
| Intracranial Hemorrhage |
0 |
0.75 |
| Social Determinants of Health |
0 |
0.25 |
| Direct Factor Xa Inhibitor |
0 |
0.19 |
| Disability |
0 |
0.19 |
| Food and Drug Administration (FDA) |
0 |
0.19 |
| Health Care Quality, Access, and Evaluation |
0 |
0.19 |
| Europe |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Ischemic Stroke |
0 |
0.1 |
| Thrombosis |
0 |
0.1 |
| Venous Thromboembolism (VTE) |
0 |
0.95 |